Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,074Revenue (TTM) $M2,821Net Margin (%)26.4Altman Z-Score1.6
Enterprise Value $M8,112EPS (TTM) $1.3Operating Margin %25.9Piotroski F-Score5
P/E(ttm)6.6Beneish M-Score-3.3Pre-tax Margin (%)44.9Higher ROA y-yY
Price/Book1.210-y EBITDA Growth Rate %--Quick Ratio1.3Cash flow > EarningsY
Price/Sales1.75-y EBITDA Growth Rate %-4.2Current Ratio1.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %1,094ROA % (ttm)8.8Higher Current Ratio y-yN
Dividend Yield %12.2PEG--ROE % (ttm)19.3Less Shares Outstanding y-yN
Payout Ratio %88.0Shares Outstanding M554ROIC % (ttm)7.0Gross Margin Increase y-yN

Gurus Latest Trades with FBR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
FBRRuane Cunniff 2009-09-30 Sold Out $10.43 - $17.15
$ 9.16-36%Sold Out0
FBRGeorge Soros 2009-09-30 Sold Out $10.43 - $17.15
$ 9.16-36%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

FBR is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

FBR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PASSPORT MANAGEMENT LLC10% Owner 2007-11-20Sell0$0view
MICHAEL RALPH S IIIDirector 2006-06-08Sell0$0view
LINDNER RUSSELL CDirector 2005-05-31Buy10,000$13.01-29.59view
GINIVAN WILLIAM JChief Legal Officer 2005-05-18Buy10,000$12.95-29.27view
TONKEL J ROCK JRPresident & Head of Inv. Bkng. 2005-05-13Buy50,000$12.26-25.29view
HENDRIX RICHARD JPresident & COO 2005-05-10Buy40,000$12.63-27.47view
GALLAGHER PETER ADirector 2004-09-16Sell6,000$20-54.2view
GALLAGHER PETER ADirector 2004-06-15Sell3,000$20-54.2view
WALL JOHN TDirector 2004-05-20Buy1,000$17.83-48.63view
LINDNER RUSSELL CDirector 2004-05-03Buy2,600$18.5-50.49view

Quarterly/Annual Reports about FBR:

    News about FBR:

    Articles On GuruFocus.com
    Gurus' Stocks With Low P/E Ratios Oct 31 2016 
    A Look at Fibria Celulose Aug 23 2016 
    Guru Stocks at 52-Week Lows Mar 14 2016 
    International Paper is Restructuring its Operations Sep 13 2014 
    Morning Coffee: Widely Held International Guru Stocks Near 52-Week Lows May 02 2014 
    10 Consumer Goods Dividend Stocks under Book Value Dec 14 2011 
    NWQ Managers Buy Arlington Asset Investment Corporation (AI) Jun 11 2009 
    Friedman Billings Ramsey Group Inc. Reports Operating Results (10-Q) May 07 2009 

    More From Other Websites
    - 6th Fibria Day Presentation Dec 01 2016
    Brazil Fibria to raise prices in US, Europe at least once in 2017 Nov 30 2016
    Clearwater (CLW) to Trim Operations on Continued Headwinds Nov 30 2016
    3 Low Cost, High Dividend Yield Stocks To Buy Now Nov 28 2016
    Acquisition of minority equity interest in CelluForce Nov 18 2016
    This Is How the Trump Victory Could Affect Brazil and Mexico Nov 11 2016
    Zacks.com featured highlights: Vail Resorts, Big 5 Sporting Goods, Stamps.com, Fibria Celulose SA... Nov 11 2016
    Fortress Biotech Reports Third Quarter 2016 Financial Results and Recent Corporate Highlights Nov 09 2016
    UBS - I Pulp & Paper Day Nov 09 2016
    Top Ranked Income Stocks to Buy for November 7th Nov 07 2016
    Fortress Biotech Forms New Subsidiary, Cellvation, Inc., to Develop Novel Therapies for the... Nov 07 2016
    Top Ranked Value Stocks to Buy for November 4th Nov 04 2016
    ETF’s with exposure to Fibria Celulose SA : November 3, 2016 Nov 03 2016
    Fibria Celulose SA :FBR-US: Earnings Analysis: Q3, 2016 By the Numbers : November 2, 2016 Nov 02 2016
    Brazilian pulpmaker Fibria swings to profit in third quarter Oct 31 2016
    - 3Q16 Earnings Release Oct 31 2016
    Data from Phase 1 Trial of Triplex Vaccine for Control of Cytomegalovirus Published in Blood Oct 28 2016
    7 Stocks Trading With Low P/E Ratios Oct 19 2016
    Journey Medical Corporation Launches Targadox™ Oral Immediate-Release Tablet for Treatment of... Oct 17 2016
    Downtrending Stocks Still Presenting Short Trades Oct 12 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)